Executing successful launches for both Monjuvi and Pemazyre, and we expect Tabrecta royalties to increase following the approvals and subsequent launches by Novartis in both the U.S. and Japan.
Utilize the input text as a context reference, choose the right relationship between 'Tabrecta' and 'Novartis' from the options.
Options: location of formation, manufacturer, chief executive officer, distributed by